- Home
- ALT vs LOCO Comparison
ALT vs LOCO Comparison
Compare ALT & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- LOCO
- Stock Information
- Founded
- ALT 1997
- LOCO 1980
- Country
- ALT United States
- LOCO United States
- Employees
- ALT N/A
- LOCO N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- LOCO Restaurants
- Sector
- ALT Health Care
- LOCO Consumer Discretionary
- Exchange
- ALT Nasdaq
- LOCO Nasdaq
- Market Cap
- ALT 348.6M
- LOCO 323.7M
- IPO Year
- ALT N/A
- LOCO 2014
- Fundamental
- Price
- ALT $4.15
- LOCO $10.05
- Analyst Decision
- ALT Strong Buy
- LOCO Buy
- Analyst Count
- ALT 7
- LOCO 2
- Target Price
- ALT $16.50
- LOCO $18.00
- AVG Volume (30 Days)
- ALT 2.8M
- LOCO 257.5K
- Earning Date
- ALT 11-06-2025
- LOCO 10-30-2025
- Dividend Yield
- ALT N/A
- LOCO N/A
- EPS Growth
- ALT N/A
- LOCO N/A
- EPS
- ALT N/A
- LOCO 0.85
- Revenue
- ALT $20,000.00
- LOCO $479,690,000.00
- Revenue This Year
- ALT N/A
- LOCO $6.13
- Revenue Next Year
- ALT N/A
- LOCO $1.56
- P/E Ratio
- ALT N/A
- LOCO $10.68
- Revenue Growth
- ALT N/A
- LOCO 1.85
- 52 Week Low
- ALT $2.90
- LOCO $8.29
- 52 Week High
- ALT $11.16
- LOCO $13.24
- Technical
- Relative Strength Index (RSI)
- ALT 58.45
- LOCO 60.63
- Support Level
- ALT $3.93
- LOCO $8.99
- Resistance Level
- ALT $4.15
- LOCO $9.88
- Average True Range (ATR)
- ALT 0.17
- LOCO 0.32
- MACD
- ALT 0.01
- LOCO 0.07
- Stochastic Oscillator
- ALT 77.42
- LOCO 99.61
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.